ULLRICH, Thomas;ACHOUR, Miloud;FAIRHURST, Robin Alec;KOZICZAK-HOLBRO, Magdalena;GRANDEURY, Arnaud;TUFILLI, Nicola;NOVARTIS AG;HATAKEYAMA, Shinji
发明人:
ACHOUR, Miloud,FAIRHURST, Robin Alec,GRANDEURY, Arnaud,HATAKEYAMA, Shinji,KOZICZAK-HOLBRO, Magdalena,TUFILLI, Nicola,ULLRICH, Thomas
申请号：
IBIB2014/059270
公开号：
WO2014/132205A1
申请日:
2014.02.26
申请国别(地区):
IB
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical composition in solid oral dosage form comprising (R)-7-(2-(1-(4-butoxyphenyl)-2-methylpropan-2-ylamino)-1-hydroxyethyl)-5- hydroxybenzo[d]thiazol-2(3H)-one acetate salt.L'invention concerne une composition pharmaceutique sous forme dosifiée orale solide contenant un sel de (R)-7-(2-(1-(4-butoxyphényl)-2-méthylpropan-2-ylamino)-1-hydroxyéthyl)-5- hydroxybenzo[d]thiazol-2(3H)-one acétate.
